FDAnews Device Daily Bulletin

CATHETER DELIVERY TECHNOLOGY ABBOTT TO ACQUIRE LICENSE TO J&J'S RAPID EXCHANGE

Nov. 18, 2005
A A

Abbott has entered worldwide licensing agreement with Johnson & Johnson for a large portfolio of intellectual property for developing and commercializing rapid exchange (RX) delivery systems and related drug-eluting stents and interventional products. According to the company release, the agreement will provide Abbott with access to patents that enhance the company's ability to bring to market an RX catheter delivery system.
PharmaBiz.com